Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription Articles published in JAMA Retrieve available abstracts of 76 articles: HTML format

Single Articles

October 2025
1. PERREAULT L
   Artificial Intelligence and Diabetes Prevention.
   JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.20099.
   PubMed    
   
   
   
2. MATHIOUDAKIS N, Lalani B, Abusamaan MS, Alderfer M, et al
   An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial.
   JAMA. 2025 Oct 27:e2519563. doi: 10.1001/jama.2025.19563.
   PubMed     Abstract available
   
   
   
3. DONOVAN LE, Lemieux P, Dunlop AD, Yamamoto JM, et al
   Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial.
   JAMA. 2025 Oct 24:e2519578. doi: 10.1001/jama.2025.19578.
   PubMed     Abstract available
   
   
   
4. KRUGER N, Schneeweiss S, Fuse K, Matseyko S, et al
   Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction.
   JAMA. 2025;334:1255-1266.
   PubMed     Abstract available
   
   
   September 2025
5. VAN DER WEL AWT, Frank CMC, Bout-Rebel R, Duijnhoven RG, et al
   Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial.
   JAMA. 2025 Sep 8:e2513668. doi: 10.1001/jama.2025.13668.
   PubMed     Abstract available
   
   
   
6. SCHNEIDER L
   1 in 4 US Adults With Diabetes Used Injectable GLP-1 Drugs Last Year.
   JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.13363.
   PubMed    
   
   
   July 2025
7. ANDERER S
   Once-Weekly Basal Insulin Matches Daily Option in Type 2 Diabetes Trial.
   JAMA. 2025 Jul 18. doi: 10.1001/jama.2025.10332.
   PubMed    
   
   
   June 2025
8. XU F
   Prevalence and Control of Diabetes Among US Adults.
   JAMA. 2025 Jun 30. doi: 10.1001/jama.2025.6305.
   PubMed    
   
   
   
9. INOUE K, Liu M, Wadhera RK
   Prevalence and Control of Diabetes Among US Adults-Reply.
   JAMA. 2025 Jun 30. doi: 10.1001/jama.2025.6308.
   PubMed    
   
   
   
10. ANDERER S
    Measuring Skin Water Loss Could Predict Diabetic Foot Ulcer Recurrence.
    JAMA. 2025 Jun 27. doi: 10.1001/jama.2025.9645.
    PubMed    
    
    
    
11. KALYANI RR, Neumiller JJ, Maruthur NM, Wexler DJ, et al
    Diagnosis and Treatment of Type 2 Diabetes in Adults: A Review.
    JAMA. 2025 Jun 23. doi: 10.1001/jama.2025.5956.
    PubMed     Abstract available
    
    
    
12. WANG Q, Zhang Z, Niu W
    Age and Sex Differences in Treatment Efficacy for Type 2 Diabetes.
    JAMA. 2025 Jun 4. doi: 10.1001/jama.2025.4413.
    PubMed    
    
    
    
13. HANLON P, Phillippo D, McAllister D
    Age and Sex Differences in Treatment Efficacy for Type 2 Diabetes-Reply.
    JAMA. 2025 Jun 4. doi: 10.1001/jama.2025.4416.
    PubMed    
    
    
    May 2025
14. RADEMAKER D, DeVries JH, van Rijn BB
    Oral Glucose-Lowering Agents and Large-for-Gestational-Age Infants in Gestational Diabetes-Reply.
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.2943.
    PubMed    
    
    
    
15. SU C
    Oral Glucose-Lowering Agents and Large-for-Gestational-Age Infants in Gestational Diabetes.
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.2940.
    PubMed    
    
    
    
16. ANDERER S
    Tirzepatide Outperforms Dulaglutide for Type 2 Diabetes Control.
    JAMA. 2025 May 2. doi: 10.1001/jama.2025.5645.
    PubMed    
    
    
    April 2025
17. ANDERER S
    Automated Insulin Delivery May Benefit Patients With Type 2 Diabetes.
    JAMA. 2025 Apr 18. doi: 10.1001/jama.2025.4670.
    PubMed    
    
    
    
18. PERLIS R, Schweitzer K
    Diabetic Retinopathy Is Massively Underscreened-an AI System Could Help.
    JAMA. 2025 Apr 18. doi: 10.1001/jama.2025.2778.
    PubMed    
    
    
    March 2025
19. DIELEMAN JL, Beauchamp M, Crosby SW, DeJarnatt D, et al
    Tracking US Health Care Spending by Health Condition and County.
    JAMA. 2025;333:1051-1061.
    PubMed     Abstract available
    
    
    
20. ANDERER S
    FDA Approves First Fast-Acting Insulin Biosimilar for Diabetes.
    JAMA. 2025 Mar 14. doi: 10.1001/jama.2025.1352.
    PubMed    
    
    
    
21. ANDERER S
    Certain Diabetes Medications May Help Lower COPD Exacerbation Risk.
    JAMA. 2025 Mar 14. doi: 10.1001/jama.2025.1357.
    PubMed    
    
    
    February 2025
22. INOUE K, Liu M, Aggarwal R, Marinacci LX, et al
    Prevalence and Control of Diabetes Among US Adults, 2013 to 2023.
    JAMA. 2025 Feb 27. doi: 10.1001/jama.2024.28513.
    PubMed    
    
    
    
23. BOCK A
    Studies Find Low Risk of Thyroid Cancer With GLP-1 Drugs for Diabetes.
    JAMA. 2025 Feb 14. doi: 10.1001/jama.2025.0248.
    PubMed    
    
    
    
24. ANDERER S
    Systematic Review Examines GLP-1 Drugs' Effectiveness and Safety in Patients Without Diabetes.
    JAMA. 2025 Feb 7. doi: 10.1001/jama.2025.0242.
    PubMed    
    
    
    
25. HANLON P, Butterly E, Wei L, Wightman H, et al
    Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
    JAMA. 2025 Feb 3:e2427402. doi: 10.1001/jama.2024.27402.
    PubMed     Abstract available
    
    
    January 2025
26. ANDERER S
    Sweetened Beverages Linked to Millions of Global Diabetes and Heart Disease Cases.
    JAMA. 2025 Jan 31. doi: 10.1001/jama.2024.28816.
    PubMed    
    
    
    
27. NICHOLLS SJ, Ni W, Rhodes GM, Nissen SE, et al
    Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial.
    JAMA. 2025;333:222-231.
    PubMed     Abstract available
    
    
    
28. POWE CE
    For Gestational Diabetes Pharmacotherapy, Insulin Reigns Supreme.
    JAMA. 2025 Jan 6. doi: 10.1001/jama.2024.27148.
    PubMed    
    
    
    
29. RADEMAKER D, de Wit L, Duijnhoven RG, Voormolen DN, et al
    Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2025 Jan 6. doi: 10.1001/jama.2024.23410.
    PubMed     Abstract available
    
    
    December 2024
30. LIMONTE CP, Pilla SJ, de Boer IH
    Diabetes and Chronic Kidney Disease.
    JAMA. 2024 Dec 26. doi: 10.1001/jama.2024.24671.
    PubMed    
    
    
    November 2024
31. 
    The Statistics of Diabetes.
    JAMA. 2024 Nov 27. doi: 10.1001/jama.2023.18494.
    PubMed    
    
    
    
32. ANDERER S
    Low-Carbohydrate Diet May Boost beta-Cell Function in Mild Type 2 Diabetes.
    JAMA. 2024 Nov 22. doi: 10.1001/jama.2024.23622.
    PubMed    
    
    
    
33. ANDERER S
    Creatine Likely a Marker, Not a Cause, of Insulin Resistance in Type 2 Diabetes.
    JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22566.
    PubMed    
    
    
    October 2024
34. LI P, Li Z, Staton E, Umpierrez GE, et al
    GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes.
    JAMA. 2024 Oct 23:e2418581. doi: 10.1001/jama.2024.18581.
    PubMed    
    
    
    
35. ANDERER S
    Weekly Insulin May Be as Effective as Once Daily for Type 2 Diabetes.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20116.
    PubMed    
    
    
    September 2024
36. DURKIN C
    Highs and Lows.
    JAMA. 2024;332:965-966.
    PubMed    
    
    
    
37. ANDERER S
    Risk Factors for Immune Checkpoint Inhibitor-Induced Diabetes Identified.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19134.
    PubMed    
    
    
    
38. ANDERER S
    FDA Approves First Automated Insulin Device for Type 2 Diabetes.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19129.
    PubMed    
    
    
    
39. MOJSOV S
    Chemistry Matters-From a Putative Peptide to Effective Treatments for Diabetes and Obesity: 2024 Lasker-DeBakey Clinical Medical Research Award.
    JAMA. 2024 Sep 19. doi: 10.1001/jama.2024.17571.
    PubMed    
    
    
    August 2024
40. HEGLAND TA, Fang Z, Bucher K
    GLP-1 Medication Use for Type 2 Diabetes Has Soared.
    JAMA. 2024 Aug 30. doi: 10.1001/jama.2024.18219.
    PubMed    
    
    
    
41. ANDERER S
    Study of Historic Famine Strengthens Link Between Prenatal Malnutrition and Type 2 Diabetes.
    JAMA. 2024 Aug 30. doi: 10.1001/jama.2024.15891.
    PubMed    
    
    
    
42. LAMAS GA, Anstrom KJ, Navas-Acien A, Boineau R, et al
    Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.
    JAMA. 2024 Aug 14:e2411463. doi: 10.1001/jama.2024.11463.
    PubMed     Abstract available
    
    
    
43. CURFMAN G
    Chelation Therapy Following Myocardial Infarction.
    JAMA. 2024 Aug 14. doi: 10.1001/jama.2024.13549.
    PubMed    
    
    
    July 2024
44. ABBASI J
    New Data on GLP-1s, Diabetic Retinopathy, and CGMs-Highlights From the ADA's Scientific Sessions.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.11510.
    PubMed    
    
    
    
45. BOCK A
    Study: Semaglutide Lowered Chronic Kidney Disease-Related Risks.
    JAMA. 2024;332:188.
    PubMed    
    
    
    
46. FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al
    Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.
    JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174.
    PubMed    
    
    
    
47. HARRIS E
    Fasting, Meal Substitute Improved Blood Sugar More Than Diabetes Drugs.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12233.
    PubMed    
    
    
    
48. HARRIS E
    Guidelines May Fall Short as More Older Adults Live With Type 1 Diabetes.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12235.
    PubMed    
    
    
    
49. MILDER DA, Milder TY, Kam P
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:170-171.
    PubMed    
    
    
    
50. HOBAI IA
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:171-172.
    PubMed    
    
    
    
51. LEVI M
    Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;332:171.
    PubMed    
    
    
    
52. HARRIS E
    Poll: Roughly 12% of US Adults Have Used a GLP-1 Drug, Even If Unaffordable.
    JAMA. 2024;332:8.
    PubMed    
    
    
    June 2024
53. LEE JM, Sharifi M, Oshman L, Griauzde DH, et al
    Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023.
    JAMA. 2024;331:2041-2043.
    PubMed    
    
    
    
54. BEHESHTIROUY S, Shayanfar A
    A Review of Thyroid Cancer.
    JAMA. 2024;331:1862-1863.
    PubMed    
    
    
    
55. BOUCAI L, Zafereo M, Cabanillas ME
    A Review of Thyroid Cancer-Reply.
    JAMA. 2024;331:1863-1864.
    PubMed    
    
    
    
56. COURCOULAS AP, Patti ME, Kirwan JP
    Medical Management vs Bariatric Surgery in Type 2 Diabetes-Reply.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.8852.
    PubMed    
    
    
    
57. FUJIEDA T
    Medical Management vs Bariatric Surgery in Type 2 Diabetes.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.8849.
    PubMed    
    
    
    May 2024
58. DIXIT AA, Bateman BT, Hawn MT, Odden MC, et al
    Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications.
    JAMA. 2024;331:1672-1673.
    PubMed    
    
    
    
59. MCKENNA M
    Produce Prescriptions Sound Good, but Data to Support Them Are Lacking-That Could Soon Change.
    JAMA. 2024;331:1433-1436.
    PubMed    
    
    
    April 2024
60. MACHIAVELLO ROMAN FJ, Azar MM, Trubin PA
    A Patient With Type 1 Diabetes and Acute Rhinosinusitis.
    JAMA. 2024 Apr 17. doi: 10.1001/jama.2024.0642.
    PubMed    
    
    
    
61. YOUNOSSI ZM
    Predicting Liver-Related Outcomes in Steatotic Liver Disease.
    JAMA. 2024;331:1274-1275.
    PubMed    
    
    
    
62. RUBIN R
    All of Us Program Illustrates What Less-Diverse Genomics Studies Might Be Missing.
    JAMA. 2024;331:1167-1168.
    PubMed    
    
    
    
63. HARRIS E
    Less Sleep Tied to Increased Risk of Diabetes Despite Healthy Diet.
    JAMA. 2024 Apr 5. doi: 10.1001/jama.2024.4498.
    PubMed    
    
    
    
64. FANG M, Wang D, Selvin E
    Prevalence of Type 1 Diabetes Among US Children and Adults by Age, Sex, Race, and Ethnicity.
    JAMA. 2024 Apr 4. doi: 10.1001/jama.2024.2103.
    PubMed    
    
    
    
65. POURKARIM F, Entezari-Maleki T
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1380.
    PubMed    
    
    
    
66. BOGGESS KA
    Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy-Reply.
    JAMA. 2024 Apr 3. doi: 10.1001/jama.2024.1383.
    PubMed    
    
    
    March 2024
67. MOZAFFARIAN D
    GLP-1 Agonists for Obesity-A New Recipe for Success?
    JAMA. 2024;331:1007-1008.
    PubMed    
    
    
    
68. THOMAS CC, Chopra K, Davis AM
    Management of Outpatients With Diabetes at High Risk of Hypoglycemia.
    JAMA. 2024 Mar 14. doi: 10.1001/jama.2024.1137.
    PubMed    
    
    
    
69. HARRIS E
    Tirzepatide Lowered Blood Pressure in People With Obesity.
    JAMA. 2024;331:821.
    PubMed    
    
    
    
70. RUDER K
    Diabetic Foot Infections and Amputations Are All Too Common-Here's What Could Move the Needle.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1016.
    PubMed    
    
    
    February 2024
71. WADDEN TA, Kushner RF, Chao AM
    Bariatric Surgery Produces Long-Term Benefits in Patients With Type 2 Diabetes: Evidence Supporting Its Expanded Use and Coverage.
    JAMA. 2024;331:643-645.
    PubMed    
    
    
    
72. COURCOULAS AP, Patti ME, Hu B, Arterburn DE, et al
    Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.
    JAMA. 2024;331:654-664.
    PubMed     Abstract available
    
    
    
73. MENG J, Tang H, Gao S
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:617-618.
    PubMed    
    
    
    
74. PARK Y, Kim NE, Lee SJ
    Early Metformin Treatment for Gestational Diabetes.
    JAMA. 2024;331:618.
    PubMed    
    
    
    
75. DUNNE F, Newman C, Smyth A
    Early Metformin Treatment for Gestational Diabetes-Reply.
    JAMA. 2024;331:618-619.
    PubMed    
    
    
    
76. ALHIARY R, Gabriele S, Kesselheim AS, Tu SS, et al
    Delivery Device Patents on GLP-1 Receptor Agonists.
    JAMA. 2024 Feb 5:e240919. doi: 10.1001/jama.2024.0919.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.